If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCeres Power Regulatory News (CWR)

Share Price Information for Ceres Power (CWR)

Share Price is delayed by 15 minutes
Get Live Data
527.00    5.50 (1.05%)
Bid:
520.00
Ask:
522.00
Spread: 2.00 (0.385%)
Market Cap: £1.13b
CWR Live PriceLast checked at - London Stock Exchange

Intraday Ceres Power Share Chart

Director/PDMR Shareholding

13 Apr 2006 16:01

Ceres Power Holdings plc13 April 2006 Ceres Power Holdings plc ("the Company") 13 April 2006 Director Dealings The Company announces details of the following exercises of options and warrantsand the sale of the following ordinary shares of 5p each ('Ordinary Shares') bycertain directors of the Company on 12 April 2006: 1. Mr. John Gunn, a non-executive director of the Company, sold 400,000Ordinary Shares at 315p per share. Mr. Gunn retains 85,280 Ordinary Shares inthe Company, representing approximately 0.15 per cent of the Company's issuedshare capital, in addition to 122,500 warrants over Ordinary Shares in theCompany. Mr. Gunn also has beneficial interests in 1,151,550 Ordinary Shares inthe Company in addition to 330,153 warrants over Ordinary Shares in the Company. 2. Mr. Philip Holbeche, Chairman of the Company, exercised 367,640 warrantsover Ordinary Shares in the Company and sold these Ordinary Shares at 315p pershare. Mr. Holbeche retains 716,400 Ordinary Shares in the Company, representingapproximately 1.25 per cent of the Company's issued share capital, together withoptions over 830,000 Ordinary Shares in the Company. 3. Dr. Peter Bance, Chief Executive of the Company, exercised 250,000options over Ordinary Shares in the Company and sold these at 315p per share.Dr. Bance retains 2,267,400 options over Ordinary Shares in the Company. 4. Dr. Andrew Baker, Operations Director of the Company, exercised 150,000options over Ordinary Shares in the Company and sold these at 315p per share.Dr. Baker retains 450,000 options over Ordinary Shares in the Company. The Company was informed on 13 April 2006 that Harry Fitzgibbons, anon-executive director of the Company, on 13 April 2006 sold 10,000 OrdinaryShares in the Company at 315p per share. Mr. Fitzgibbons' total holding in theCompany is now 160,000 Ordinary Shares, representing approximately 0.3% of theCompany's issued share capital. Enquiries: Matt Stride, Company Secretary +44 (0) 1293 400 404Peter Bance, CEO +44 (0) 1293 400 404 Numis Securities Limited +44 (0) 20 7776 1500David Poutney, James Black M Communications +44 (0) 20 7153 1531Lisa Gordon, Patrick D'Ancona, Charlotte Kirkhan This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
19th Sep 201912:01 pmRNSHolding(s) in Company
5th Sep 20197:00 amRNSFirst Range Extender Bus Prototype
3rd Sep 20197:00 amRNSNotice of Results
30th Jul 20193:00 pmRNSHolding(s) in Company
15th Jul 20197:00 amRNSAgreement with Doosan
9th Jul 20197:00 amRNSTrading Update
21st Jun 20197:00 amRNSBlock Listing Return
20th Jun 20197:00 amRNSJapanese Product Launch
18th Jun 20197:00 amRNSBlock Admission Application
14th May 20197:00 amRNSDirectors' Dealings and Total Voting Rights
8th May 20197:00 amRNSTotal Voting Rights
30th Apr 20197:00 amRNSGrant of Share Options under Sharesave Scheme
28th Mar 20197:00 amRNSHalf-year Report
22nd Mar 20197:00 amRNSChange of Adviser
13th Mar 20191:13 pmRNSNotice of Results
4th Mar 20197:00 amRNSHolding(s) in Company
8th Feb 20194:05 pmRNSHolding(s) in Company
1st Feb 20197:00 amRNSTotal Voting Rights
21st Dec 20187:00 amRNSBlock Listing Return
21st Dec 20187:00 amRNSHolding(s) in Company
14th Dec 201812:17 pmRNSBlock Admission Application
14th Dec 201811:45 amRNSHolding(s) in Company
12th Dec 20187:00 amRNSWeichai equity investment and total voting rights
11th Dec 20183:19 pmRNSDirector's Dealing
6th Dec 20187:05 amRNSDirectorate Change
6th Dec 20187:00 amRNSTrading Update
5th Dec 20184:28 pmRNSResult of AGM
4th Dec 20187:00 amRNSFinalised strategic collaboration, JV with Weichai
3rd Dec 20188:29 amRNSStatement regarding Weichai
12th Nov 20181:23 pmRNSNotice of Annual General Meeting
11th Oct 20187:00 amRNSGrant of Long Term Incentive Plan
11th Oct 20187:00 amRNSHolding(s) in Company
9th Oct 201812:38 pmRNSHolding(s) in Company
9th Oct 20187:00 amRNSFinal Results
8th Oct 20187:00 amRNSNew Fuel Cell Manufacturing Facility Launched
5th Oct 20187:00 amRNSWeichai Equity Investment / Total Voting Rights
26th Sep 20181:32 pmRNSTotal Voting Rights
25th Sep 20187:00 amRNSBoard Changes
24th Sep 20187:00 amRNSBosch £9 Million Equity Investment
11th Sep 20189:05 amRNSNotice of Final Results and Annual General Meeting
21st Aug 20187:00 amRNSBosch strategic collaboration, equity investment
7th Aug 20187:00 amRNSShare consolidation
2nd Aug 201811:30 amRNSHolding(s) in Company
2nd Aug 20187:00 amRNS£7m UK funding won for EV application with Nissan
31st Jul 20188:40 amRNSTR-1: NOTIFICATION
31st Jul 20187:00 amRNSDirector Retirement
30th Jul 20184:45 pmRNSHolding(s) in Company
27th Jul 20184:01 pmRNSAdmission to trading of new ordinary shares
20th Jul 20181:20 pmRNSResult of General Meeting
11th Jul 20183:10 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.